Mommy Makeover in India and UAE | Complete Patient Guide

• IDEAL CANDIDATES (INCLUSION CRITERIA):

• Women who have completed childbearing (surgery is contraindicated in patients planning future pregnancies, as subsequent pregnancies will reverse abdominal and breast results)

• BMI ≤ 30 kg/m² at time of surgery; patients with BMI 30–35 may be considered on a case-by-case basis by the operating surgeon after risk stratification

• Minimum 6 months postpartum and fully weaned from breastfeeding for a minimum of 3–6 months (to allow complete glandular involution and stabilization of breast volume)

• Presence of clinically significant diastasis recti (inter-recti distance ≥ 2.0 cm confirmed on ultrasound or clinical examination)

• Grade I–III breast ptosis per Regnault classification, with or without volume loss requiring augmentation

• Non-smoker or confirmed smoking cessation for a minimum of 6 weeks pre-operatively and 6 weeks post-operatively (nicotine causes microvascular vasoconstriction, dramatically increasing wound dehiscence and flap necrosis risk)

• Psychologically stable, with realistic, informed expectations documented in pre-operative consultation notes

• No active systemic infection, uncontrolled diabetes (HbA1c ≤ 7.5% preferred), or poorly controlled hypertension

• REQUIRED PRE-OPERATIVE DIAGNOSTICS:

• Full blood count (FBC), comprehensive metabolic panel (CMP), coagulation profile (PT, aPTT, INR)

• HbA1c for patients with diabetes or metabolic syndrome

• Thyroid function tests (TSH, Free T4) — thyroid dysfunction affects wound healing and anesthetic risk

• Serum albumin and pre-albumin (nutritional status assessment, critical for wound healing)

• 12-lead ECG and anesthesiologist-led cardiopulmonary risk assessment (ASA classification)

• Mammogram or breast ultrasound (patients ≥ 35 years, or any age with family history of breast malignancy, to rule out occult pathology before implant placement)

• 3D surface imaging scan (Vectra XT or equivalent) for surgical planning and outcome simulation

• Abdominal wall ultrasound to quantify inter-recti distance and assess fascial integrity

• Venous Doppler ultrasound of lower limbs if personal or family history of DVT/PE (Caprini Risk Score assessment mandatory for all patients)

• ABSOLUTE CONTRAINDICATIONS:

• Active or recent (within 5 years) breast malignancy

• Active systemic autoimmune disease requiring immunosuppressive therapy

• Uncontrolled coagulopathy or bleeding disorder

• Planned future pregnancy

• Active smoking within 6 weeks of surgery

• Morbid obesity (BMI > 40 kg/m²)

• Severe cardiopulmonary disease (ASA Class III–IV)

• Unrealistic expectations or body dysmorphic disorder (BDD) — psychological screening is mandatory

CORE SURGICAL COMPONENTS AND TECHNIQUES:

1. ABDOMINOPLASTY (TUMMY TUCK) — VARIANTS AND SELECTION CRITERIA:

• Full Abdominoplasty with Rectus Plication: The gold standard for patients with significant skin excess below the umbilicus, moderate-to-severe diastasis recti, and lax abdominal wall. A low transverse incision is placed within or just above the pubic hairline (designed for concealment in swimwear). The anterior abdominal skin-fat flap is elevated in the supra-fascial plane to the costal margins, the rectus sheath is plicated in the midline using permanent sutures (typically 0-PDS or 0-Prolene in a double-layered running or interrupted technique), the umbilicus is transposed through a new umbilicoplasty incision, and excess skin is excised. High-definition muscle marking with VASER can be combined.

• Mini Abdominoplasty: Indicated for patients with skin laxity limited to the infraumbilical zone and mild diastasis. No umbilical transposition is required; the scar is shorter.

• Extended Abdominoplasty / Fleur-de-Lis: Reserved for patients with significant lateral and vertical skin excess (common after massive weight loss). Adds a vertical midline scar to achieve maximal skin excision.

• Drainless Abdominoplasty (Progressive Tension Sutures / Quilting Technique): A modern advancement where quilting sutures (Strattice or barbed Quill sutures) obliterate the dead space between the flap and the fascia, eliminating the need for surgical drains, reducing seroma formation, and accelerating recovery.

2. LIPOSUCTION — TECHNOLOGIES:

• Power-Assisted Liposuction (PAL / MicroAire): Mechanical oscillation of the cannula reduces surgeon fatigue and improves fat cell disruption efficiency. First-line technology in most centers.

• VASER Ultrasound-Assisted Liposuction (UAL): Ultrasonic energy selectively emulsifies adipocytes while preserving neurovascular structures. Superior for fibrous areas (flanks, back, male chest). Enables high-definition body contouring by selectively preserving fat over muscular landmarks.

• BodyTite / FaceTite (Radiofrequency-Assisted Liposuction, RFAL): Simultaneous internal radiofrequency delivery via a bipolar probe causes adipocyte disruption AND dermal collagen contraction, providing measurable skin tightening (30–40% skin surface area reduction demonstrated in clinical studies). Ideal for patients with mild-to-moderate skin laxity who are not candidates for surgical excision.

• Renuvion (J-Plasma Subdermal Coagulation): Helium plasma energy delivered subdermally to achieve aggressive skin tightening as an adjunct to liposuction. An emerging technology available at select premium centers.

3. BREAST PROCEDURES — OPTIONS:

• Breast Augmentation with Cohesive Silicone Gel Implants: Fifth-generation, form-stable, textured or smooth round or anatomical (teardrop) implants placed via inframammary fold, periareolar, or transaxillary approach. Implant placement is either submuscular (dual-plane), subglandular, or subfascial depending on tissue coverage and ptosis grade. The Dual-Plane technique (Types I, II, III as classified by Tebbetts) is the most versatile, accommodating mild-to-moderate ptosis while providing adequate implant coverage.

• Breast Augmentation with Autologous Fat Transfer (Natural Augmentation / Lipofilling): Harvested, centrifuged, or filtered fat (Coleman technique or closed-loop systems such as Revolve or Puregraft) is injected in micro-aliquots into the breast parenchyma and subcutaneous tissue. Provides 1–1.5 cup sizes of enhancement without implants. Ideal for patients desiring natural augmentation without foreign material. Requires sufficient donor-site fat volume.

• Mastopexy (Breast Lift) — Scar Pattern Selection:

- Crescent mastopexy: For Grade I ptosis with < 1 cm nipple descent correction needed.

- Periareolar (Benelli / Round-block) mastopexy: Grade I–II ptosis.

- Vertical (Lollipop / Lejour) mastopexy: Grade II ptosis, preferred for its superior long-term shape and minimal horizontal scarring.

- Wise-pattern (Inverted-T / Anchor) mastopexy: Grade III ptosis or post-massive-weight-loss patients with severe ptosis and skin excess.

• Augmentation-Mastopexy (Combined): Technically the most demanding breast procedure in a Mommy Makeover; requires precise balance between implant expansion force and mastopexy tension to avoid implant malposition, wound dehiscence, or nipple-areolar complex ischemia.

• Breast Reduction (Reduction Mammaplasty): For patients with symptomatic macromastia (neck pain, intertrigo, bra-strap grooving). Superior pedicle or Wise-pattern technique most commonly employed.

4. ADJUNCT PROCEDURES:

• Labiaplasty (Labia Minora Reduction): Trim technique or wedge resection technique to address labial hypertrophy aggravated by childbirth.

• Monsplasty (Pubic Lift): Excision of excess pubic fat and skin as part of the lower abdominal approach.

• Nipple-Areolar Complex (NAC) Reduction: Frequently performed in conjunction with mastopexy.

5. ANESTHESIA AND SAFETY TECHNOLOGY:

• All procedures performed under general anesthesia administered by a board-certified anesthesiologist or anesthesia team.

• BIS (Bispectral Index) monitoring for depth-of-anesthesia assessment.

• Intraoperative cell salvage where applicable.

• Sequential compression devices (SCDs) and pneumatic compression stockings activated at induction; maintained throughout the procedure.

• Patient warming systems (Bair Hugger) to prevent hypothermia, a modifiable risk factor for coagulopathy.

• Total operative time is carefully planned to remain under 6 hours for single-session combined procedures, reducing anesthetic risk and DVT risk.

PRE-OPERATIVE PHASE (4–8 Weeks Before Surgery):

Step 1 — Virtual Consultation with GAF Healthcare (Week -8 to -6): Submit photographs, medical history, and goals via the GAF Healthcare portal. A GAF case manager assigns a shortlisted board-certified plastic surgeon at an accredited center. A video consultation with the surgeon is arranged. The surgeon reviews submitted photographs, requests diagnostic tests, and provides a detailed surgical plan with a personalized cost estimate.

Step 2 — Diagnostic Workup (Week -6 to -4): The patient completes all required pre-operative tests (blood work, ECG, mammogram, abdominal ultrasound) at a local facility. Reports are shared digitally with the operating surgeon for review and anesthetic pre-assessment.

Step 3 — Pre-Travel Preparation (Week -4 to -2): GAF Healthcare initiates e-Medical Visa application for India (or entry visa/visa-on-arrival coordination for UAE). Medical travel insurance is arranged. Accommodation for the patient and one attendant is confirmed. The patient initiates smoking cessation, discontinues anticoagulants (aspirin, NSAIDs, blood thinners) as instructed, commences nutritional optimization (high-protein diet, Vitamin C, Vitamin D, iron supplementation if indicated), and begins pre-operative abdominal exercises to improve core strength.

Step 4 — Arrival and Final Consultation (Day -2 to -1): GAF Healthcare airport transfer arranged. Hospital admission and pre-operative nursing assessment completed. Final surgical consultation with the operating surgeon: markings are reviewed, implant sizes confirmed using sizers, and informed consent is completed. Anesthesiologist pre-operative assessment and ASA classification confirmed. NPO (nil by mouth) instructions issued from midnight before surgery.

INTRA-OPERATIVE PHASE (Day 0 — Surgery Day):

Step 5 — Operative Procedure (Duration: 4–6 hours for full combined Mommy Makeover; up to 8 hours for complex cases): Patient admitted to the pre-operative suite, IV access established, SCDs applied, warming blanket applied. General anesthesia induced. Surgeon executes pre-marked surgical plan: typically, liposuction is performed first (to harvest fat for lipofilling if required and to debulk areas before skin excision), followed by abdominoplasty with rectus plication, then breast procedures. Incisions are closed in layered fashion using deep absorbable sutures (Vicryl, Monocryl) and skin closure strips or subcuticular sutures. Compression garments are applied in the OR. Patient transferred to recovery.

POST-OPERATIVE PHASE — IN-HOSPITAL (Day 1–3):

Step 6 — Immediate Post-Operative Recovery (Hours 4–24): Patient observed in the recovery room for 2–4 hours. IV fluids, multimodal analgesia commenced (liposomal bupivacaine wound block, IV acetaminophen, ketorolac, ondansetron for nausea). Early ambulation (supervised walking) initiated within 8–12 hours post-operatively to reduce DVT risk. Drain output monitored if drains placed.

Step 7 — Inpatient Stay (Day 1–3): Daily wound review, drain management, and physiotherapy-assisted mobility exercises. Oral diet progressed as tolerated. Enoxaparin (DVT prophylaxis) commenced as per protocol. Patient education on garment care, wound hygiene, and activity restrictions. Drains removed when output < 30 mL/24 hours (typically Day 2–4).

POST-OPERATIVE PHASE — OUTPATIENT RECOVERY (Week 1–5 in Country):

Step 8 — Week 1 (Days 4–7): Discharge to GAF-arranged accommodation (serviced apartment or hotel with medical-grade support). Rest, ambulation in small increments, lymphatic drainage massage initiated (manual lymphatic drainage, MLD). Compression garment worn 24/7. Post-operative nursing visits arranged by GAF Healthcare. First outpatient wound review at Day 5–7.

Step 9 — Week 2 (Days 8–14): Sutures/strips reviewed and removed where applicable. Swelling and bruising at peak, beginning to subside. Patient may begin light activities (short walks). Abdominal binder and breast support garments continued. Scar management initiated: medical-grade silicone sheets or gels applied from Day 14 onward.

Step 10 — Week 3 (Days 15–21): Surgeon final pre-flight clearance consultation. Caprini DVT Risk Score reassessed. Aspirin (81 mg daily) commenced 5 days before flight as per many surgeons' protocols for long-haul travel. FIT-TO-FLY certificate issued by the operating surgeon (minimum 3 weeks post-op for most patients; 4–5 weeks recommended for complex combined cases or patients with higher DVT risk).

Step 11 — Weeks 4–6 (Post-Departure): Remote follow-up via GAF Healthcare telemedicine portal. Patients return to sedentary desk work by Week 4–6. Strenuous exercise and heavy lifting restricted until Week 6–8. Final results visible at 3–6 months as swelling fully resolves and scars mature (scar maturation continues for 12–18 months).

KEY RECOVERY MILESTONES:

• Return to sedentary work: 2–4 weeks

• Return to driving: 3–4 weeks (when off opioid analgesics and able to perform emergency braking)

• Return to light exercise (walking, yoga): 6 weeks

• Return to strenuous exercise / heavy lifting: 8–12 weeks

• Final aesthetic result (swelling fully resolved): 3–6 months

• Scar maturation: 12–18 months